- Bharat Electronics is scheduled to announce its Q4 2026 results on May 19 following a strong 10% gain in year-to-date performance
- The massive ₹74,000 crore rupee order book provides significant long-term revenue visibility and remains a critical metric for future stock performance
- Strong government support for domestic defense manufacturing acts as a primary tailwind for the stock as it approaches key resistance levels.
Bharat Electronics Limited (NSE: BEL) has been a standout performer in the defense portfolio this year. The stock has enjoyed a solid flight path so far in 2026, gaining nearly 10% year-to-date. However, as we approach the mid-month mark, attention shifts to the upcoming results.
BEL is officially slated to report its Q4 FY26 results on May 19, 2026, and significant anticipation surrounds these results. For investors, the question extends beyond merely whether the company surpassed market expectations, to whether its multi-year growth momentum continues effectively.
Strong FY26 Backdrop Sets the Stage
FY26 concluded with a robust performance, as BEL achieved a provisional turnover reaching a record of approximately ₹26,750 crore, an increase of roughly 16% year-over-year. Order inflows amounted to ₹30,000 crore, including substantial exports, and the order book remained strong at around ₹74,000 crore as of April 1, 2026. This provides significant revenue visibility for the upcoming years.
Q4 is typically a strong quarter for execution in defence PSUs. Financial analysts, including Motilal Oswal, forecast revenue nearing ₹10,230 crore, representing an increase of approximately 12-14% year-over-year, with net profit close to ₹2,168 crore, indicating a modest 3% year-over-year growth given the strong prior-year comparison. EBITDA margins could experience some sequential pressure due to the product mix but are projected to remain robust within the mid-to-upper 20% range.
The Real Story Is In the Order Book
While the profit and loss statement provides one perspective, the order book often offers a more significant indicator of future financial health, and in this aspect, BEL demonstrates notable strength. As of April 1, 2026, the executable order book totaled approximately ₹74,000 crore. This provides nearly three years of revenue visibility at current operational rates.
During FY26 alone, BEL successfully secured new orders valued at close to ₹30,000 crore. The orders encompassed a range of areas such as radar technology, avionics, electronic warfare systems, and communication infrastructure.
The strong order momentum has persisted into FY27. Recently, the company secured a ₹1,251 crore order to supply Ground Based Multi-Function Electronic Systems (GBMES) to the Indian Army. It also received orders totaling ₹569 crore for avionics, electronic warfare systems, lasers, and spare parts on April 22. Such a sustained pace of new orders, if validated by management during the earnings call, would likely instill significant confidence among long-term investors.
The Three Metrics That Matter Most
EBITDA margin is the first thing analysts will check. Management has guided for margins of 27% or above for FY26. Any deviation will immediately signal whether cost discipline is holding as BEL scales up. Second, order inflow and closing order book will be key, given that BEL’s revenue visibility is its biggest premium driver.
An order book closing within the ₹73,000–₹75,000 crore range or higher would likely be viewed favorably. Third, management’s outlook for FY27, particularly concerning the potential QRSAM mega-order, new defense contracts linked to Georgia, and the anticipated acceleration in exports, all of which are currently in development. The direction communicated by leadership regarding the upcoming year could hold greater significance than the reported figures alone.
Potential Stock Impact
If the company does better than expected with its sales and orders, and gives a strong guidance for the 2027 fiscal year, the stock could easily jump up 5-10% pretty quickly. The defense industry gets a lot of government backing. So, any surprisingly big new contracts, like for QRSAM, would really help push things along.
On the flip side, if margins disappoint sharply or execution commentary is cautious. The stock is already priced quite high, so if they miss their targets, people might start selling shares to take their profits. It’s a good company, but it’s not immune to what the wider market is doing or if investors decide it’s simply too expensive.
